Manuscripts
Showing 1592 manuscripts.
Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women With HIV
Citation
Nicole H. Tobin, Sarah Brooker, Fan Li, Yoninah S. Cramer, Susan Rosenkranz, Robert W. Coombs, Susan E. Cohn, Carmen Zorrilla, Laura Moran, Baiba Berzins, Kimberly K. Scarsi, Catherine Godfrey, Grace M. Aldrovandi, ACTG 5316 Team. Use of an Ethinyl Estradiol/Etonogestrel Vaginal Ring Alters Vaginal Microbial Communities in Women With HIV. Journal of Infectious Diseases. 2025 Mar 17; 231(3):583-594. PMID: 39479902; PMCID: 11911790.Year
2025
Journal
Journal of Infectious Diseases
Altered milk tryptophan and tryptophan metabolites and health of children born to women with HIV
Citation
Nicole H. Tobin, Fan Li, Wentao Zhu, Kathie G. Ferbas, John W. Sleasman, Daniel Raftery, Louise Kuhn, Grace M. Aldrovandi. Altered milk tryptophan and tryptophan metabolites and health of children born to women with HIV. Nature Communications. 2025 Mar 21; 16(1):9437. PMID: 41152239; PMCID: PMC12568960.Year
2025
Journal
Nature Communications
Mixing of Tecovirimat in Water to Support Oral Dosing of Infants and Children With Mpox
Citation
Z. Wei, Kristina Brooks, Sharon Nachman, Grace Aldrovandi, Timothy Wilkin, William Fischer, Jennifer Kiser, Jason Zucker. Mixing of Tecovirimat in Water to Support Oral Dosing of Infants and Children With Mpox. 2025 Mar 12; PMID: 39953939; PMCID: 11926593.Year
2025
Study
A5418
Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens
Citation
Christopher Alba, Shelly Malhotra, Stephanie Horsfall, Matthew E. Barnhart, Adrie Bekker, Katerina Chapman, Coleen K. Cunningham, Patricia E. Fast, Genevieve G. Fouda, Kenneth A. Freedberg, Ameena Goga, Lusine R. Ghazaryan, Valériane Leroy, Carlyn Mann, Margaret M. McCluskey, Elizabeth J. McFarland, Vincent Muturi-Kioi, Sallie R. Permar, Roger Shapiro, Devin Sok, Lynda Stranix-Chibanda, Milton C. Weinstein, Andrea L. Ciaranello, Caitlin M. Dugdale. Cost-effectiveness of broadly neutralizing antibodies for HIV prophylaxis for infants born in settings with high HIV burdens. PLoS One. 2025 Mar 19; 20(3):e0318940. PMID: 40106399; PMCID: 11922280.Year
2025
Journal
PLoS One
Study
P1112
Influence of Distinct Maternal Cytomegalovirus-Specific Neutralizing and Fc Receptor-Binding Responses on Congenital Cytomegalovirus Transmission in HIV-Exposed Neonates
Citation
Itzayana G Miller, Aakash Mahant Mahant, Jennifer A Jenks, Eleanor C Semmes, Eric Rochat, Savannah L Herbek, Caroline Andy , Nicole S Rodgers, Justin Pollara, Linda M Gerber, Betsy C Herold, Sallie R Permar. Influence of Distinct Maternal Cytomegalovirus-Specific Neutralizing and Fc Receptor-Binding Responses on Congenital Cytomegalovirus Transmission in HIV-Exposed Neonates. Viruses. 2025 Feb 26; 17(3):325. PMID: 40143253; PMCID: 11946089.Year
2025
Journal
Viruses
ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept study
Citation
Deborah Persaud, Anne Coletti, Bryan S. Nelson, Jennifer Jao, Edmund V. Capparelli, Diane Costello, Camlin Tierney, Adeodata R. Kekitiinwa, Teacler Nematadzira, Boniface N. Njau, John Moye, Patrick Jean-Philippe, Violet Korutaro, Annet Nalugo, Tapiwa Mbengeranwa, Tinashe Chidemo, Blandina T. Mmbaga, Philoteus A. Sakasaka, Mark Cotton, Cheryl Jennings, Carly Hoffmann, Laura Hovind, Yvonne Bryson, Ellen G Chadwick, IMPAACT P1115 Study Team. ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept study. Lancet HIV. 2025 Nov 15; 12(11):e743-e752. PMID: 41015049; PMCID: PMC13047515.Year
2025
Journal
Lancet HIV
Study
P1115
Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During
Pregnancy and the Postpartum Period: Results From IMPAACT P1026s
Citation
Jennifer A. Hughes, Flynn McMorrow, Kristina M. Brooks, Mauricio Pinilla, Lee Fairlie, James S. Ngocho, Alice Stek, Brookie M. Best, Mark Mirochnick, Lubbe Wiesner, Kathleen George, Kevin Knowles, Renee Browning, Tara DeYampert, Anneke C. Hesseling, Eric Decloedt, David E. Shapiro, Ahizechukwu C. Eke, IMPAACT P1026s Protocol Team. Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026s. Journal of Infectious Diseases. 2025 Oct 30; 233(1):16-26. PMID: 41165222; PMCID: PMC12811852.Year
2025
Journal
Journal of Infectious Diseases
Study
P1026S
Breast Milk Transfer and Infant Exposures to Dolutegravir, Tenofovir, and Tenofovir Alafenamide: Results from IMPAACT 2010/VESTED
Citation
Tk Nguyen, Jung-Woo Chae, Lauren Ziemba, Anne Coletti, Kevin Knowles, Benjamin Johnston, Patrick Jean-Philippe, Tsungai Mhembere, Tariro Chawana, Deo Wabwire, Violet Korutaro, Sikhulile Moyo, Patricia Mandima, Siphokazi Sibisi, Avy Violari, Sherika Hanley, Blandina Mmbaga, Gaerolwe Masheto, Ponego Ponatshego, Gerhard Theron, Shilpa N Naik, Roger Shapiro, Shahin Lockman, Lameck Chinula, Jeremiah D. Momper, IMPAACT 2010/VESTED Protocol Team. Breast Milk Transfer and Infant Exposures to Dolutegravir, Tenofovir, and Tenofovir Alafenamide: Results from IMPAACT 2010/VESTED. Journal of Acquired Immune Deficiency Syndromes. 2025 Nov 06; Online ahead of print. PMID: 41195894; PMCID: PMC12684287.Year
2025
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
IMPAACT 2010
Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices during Pregnancy and Postpartum
Citation
Yifan Yu, Kristina M. Brooks, Gustavo F. Doncel, Brookie M. Best, Mark A. Marzinke, Mark Mirochnick, Peter Anderson, Landon Myer, Connie Celum, Renee Heffron, Jenell Coleman, Dvora Joseph Davey, Craig W. Hendrix, Jeremiah D. Momper, Robert Bies, Rachel K. Scott. Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices during Pregnancy and Postpartum. Clinical Pharmacokinetics. 2025 Nov 12; 65(1):133-148. PMID: 41222898; PMCID: PMC12783228.Year
2025
Journal
Clinical Pharmacokinetics
Study
P1026S, IMPAACT 2026
Are Family Factors Differentially Associated with Externalizing Symptoms Among Youth with Perinatally Acquired HIV?
Citation
Deborah A G Drabick, Rafaella J Jakubovic, Abbey L Friedman, Valerie S Everett, George O Emory, Marianela Rosales Gerpe, Katherine M Deloreto, Aidan P Campagnolio, Mary Katherine Galante, Sharon Nachman, Kenneth D Gadow. Are Family Factors Differentially Associated with Externalizing Symptoms Among Youth with Perinatally Acquired HIV?. Child Psychiatry & Human Development. 2025 Dec 01; 56(6):1559-1572. PMID: 38261149.Year
2025
Journal
Child Psychiatry & Human Development
Study
P1055